A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2
320
about 2.7 years
18+
25 sites in AZ, CA, CO +9
About this study
This trial is testing a treatment called AZD1163 for people with rheumatoid arthritis. The goal is to see if this treatment helps improve symptoms and is safe.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take AZD1163
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Change From Baseline in Disease Activity Score-C-Reactive Protein (DAS28-CRP) at Week 12
Secondary: Change From Baseline in Clinical Disease Activity Index (CDAI) at Week 12, Change From Baseline in Simplified Disease Activity Index (SDAI) at Week 12, Summary statistics to evaluate the PK of AZD1163
Immune